Anbio Biotechnology Class A Ordinary Shares (NNNN) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Anbio Biotechnology Class A Ordinary Shares (NNNN) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $336.6M, listed on NASDAQ, employing roughly 27 people, carrying a beta of 5.35 to the broader market. Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. Led by Michael Lau, public since 2025-02-19.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for NNNN as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →